x

Search for a clinical trial

* (*) mandatory field

EARLY: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Bosentan in Patients With Mildly Symptomatic Pulmonary Arterial Hypertension (PAH) (Phase III) (completed)

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Actelion pharmaceuticals ltd.
  • Website
  • Principal investigator of clinical trial

  • Dr Miguel Ángel GÓMEZ SÁNCHEZ
  • Unidad Multidisciplinar de Hipertensión Pulmonar
  • Hospital Universitario 12 de Octubre
  • Avenida de Córdoba s/n
  • 28041 MADRID
  • SPAIN
  • More information
  • Phone  : 
    34 91 390 80 00 ext.4471-4642
  • Fax  : -
  • Website
  • Contact secretary  :
Last update: May 2012

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.